BlackRock »

Enzo Biochem shares owned by BlackRock

Quarter-by-quarter ownership of Enzo Biochem (ENZ) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Enzo Biochem

Tip: Access up to 7 years of quarterly data

All positions including Enzo Biochem held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enzo Biochem by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 959k 1.12

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Enzo Biochem

Renaissance Technologies
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Dimensional Fund Advisors
State Street Corporation
Bridgeway Capital Management
BBR Partners
Nierenberg Investment Management Company
Morgan Stanley
Northern Trust
Lazard Asset Management
T. Rowe Price Associates
Citadel Advisors

View all funds holding Enzo Biochem